Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00597376 · ClinicalTrials.gov registry record · NA
Study of the Effects of Cerefolin NAC on Inflammation Blood Markers in Older Individuals With Memory Complaints
A NA study, sponsored by Rush University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT00597376 is a NA study that has completed, run by Rush University Medical Center. The registered enrollment target is 104 participants.
The verdict
NCT00597376, a NA study, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
The purpose of this six-month research study is to determine if Cerefolin NAC reduces levels of substances in the blood that may be associated with thinking ability and the health of brain cells in subjects with memory concerns when compared to a standard multivitamin. Cerefolin NAC is available as a dietary supplement via a prescription from a physician. The multivitamin used in the study contains the Recommended Daily Intake recommended for older persons.
Interventions
- OTHER Cerefolin NAC (a medical food)
- OTHER Cerefolin NAC placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2007-11 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00597376
The ClinicalTrials.gov registry entry for NCT00597376 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cerefolin NAC (a medical food) is the first listed.
NCT00597376 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00597376 about?
NCT00597376 is a clinical study titled "Study of the Effects of Cerefolin NAC on Inflammation Blood Markers in Older Individuals With Memory Complaints". The purpose of this six-month research study is to determine if Cerefolin NAC reduces levels of substances in the blood that may be associated with thinking ability and the health of brain cells in subjects with memory concerns when compared to a standard multivitamin. Cerefolin NAC is available as ...
What is the current status of trial NCT00597376?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2007-11. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00597376?
The interventions under investigation include: Cerefolin NAC (a medical food) (OTHER), Cerefolin NAC placebo (OTHER).
Who is sponsoring clinical trial NCT00597376?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.